97 related articles for article (PubMed ID: 17003934)
1. Hypofibrinogenaemia associated with common gamma82Ala-->Gly mutation is not mediated by altered mRNA splicing.
Brennan SO; Homer VM; Davis RL; Meyer M; George PM
Thromb Haemost; 2006 Oct; 96(4):535-7. PubMed ID: 17003934
[No Abstract] [Full Text] [Related]
2. A deep intronic mutation in FGB creates a consensus exonic splicing enhancer motif that results in afibrinogenemia caused by aberrant mRNA splicing, which can be corrected in vitro with antisense oligonucleotide treatment.
Davis RL; Homer VM; George PM; Brennan SO
Hum Mutat; 2009 Feb; 30(2):221-7. PubMed ID: 18853456
[TBL] [Abstract][Full Text] [Related]
3. Hypofibrinogenaemia caused by a novel FGG missense mutation (W253C) in the gamma chain globular domain impairing fibrinogen secretion.
Vu D; de Moerloose P; Batorova A; Lazur J; Palumbo L; Neerman-Arbez M
J Med Genet; 2005 Sep; 42(9):e57. PubMed ID: 16141000
[TBL] [Abstract][Full Text] [Related]
4. Fibrinogen Leipzig II (gamma351Gly-->Ser and gamma82Ala-->Gly): hypodysfibrinogenaemia due to two independent amino acid substitutions within the same polypeptide chain.
Meyer M; Dietzel H; Kaetzel R; Schmidt D; Liebscher K; Brennan SO
Thromb Haemost; 2007 Oct; 98(4):903-5. PubMed ID: 17938819
[No Abstract] [Full Text] [Related]
5. Mutations in the fibrinogen gene cluster accounting for congenital afibrinogenemia: an update and report of 10 novel mutations.
Neerman-Arbez M; de Moerloose P
Hum Mutat; 2007 Jun; 28(6):540-53. PubMed ID: 17295221
[TBL] [Abstract][Full Text] [Related]
6. [Congenital afibrinogenemia: focusing on molecular mechanisms controlling fibrinogen secretion].
Vu D; Neerman-Arbez M
Med Sci (Paris); 2006 Feb; 22(2):117-20. PubMed ID: 16457748
[No Abstract] [Full Text] [Related]
7. Expression of four mutant fibrinogen gammaC domains in Pichia pastoris confirms them as causes of hypofibrinogenaemia.
Sheen CR; Dear A; Brennan SO
Protein Expr Purif; 2010 Oct; 73(2):184-8. PubMed ID: 20580674
[TBL] [Abstract][Full Text] [Related]
8. Clinical and molecular characterisation of 21 patients affected by quantitative fibrinogen deficiency.
Asselta R; Platè M; Robusto M; Borhany M; Guella I; Soldà G; Afrasiabi A; Menegatti M; Shamsi T; Peyvandi F; Duga S
Thromb Haemost; 2015 Mar; 113(3):567-76. PubMed ID: 25427968
[TBL] [Abstract][Full Text] [Related]
9. A novel fibrinogen Bbeta chain frameshift mutation in a patient with severe congenital hypofibrinogenaemia.
Xu X; Wu J; Zhai Z; Zhou R; Wang X; Wang H; Ding K; Sun Z; Ni H
Thromb Haemost; 2006 Jun; 95(6):931-5. PubMed ID: 16732370
[TBL] [Abstract][Full Text] [Related]
10. Congenital afibrinogenemia: mutations leading to premature termination codons in fibrinogen A alpha-chain gene are not associated with the decay of the mutant mRNAs.
Asselta R; Duga S; Spena S; Santagostino E; Peyvandi F; Piseddu G; Targhetta R; Malcovati M; Mannucci PM; Tenchini ML
Blood; 2001 Dec; 98(13):3685-92. PubMed ID: 11739173
[TBL] [Abstract][Full Text] [Related]
11. Novel fibrinogen mutation γ314Thr→Pro (fibrinogen AI duPont) associated with hepatic fibrinogen storage disease and hypofibrinogenaemia.
Brennan SO; Davis RL; Conard K; Savo A; Furuya KN
Liver Int; 2010 Nov; 30(10):1541-7. PubMed ID: 20666993
[TBL] [Abstract][Full Text] [Related]
12. Clinical and biological features of 3 cases of hypofibrinogenemia associated with three different mutations (gamma Ala341Thr, Bbeta Tyr326Cys and Aalpha Asp496Asn).
Hanss M; Chevreaud C; French P; Négrier C; de Mazancourt P
Thromb Haemost; 2007 Sep; 98(3):689-91. PubMed ID: 17849064
[No Abstract] [Full Text] [Related]
13. Afibrinogenemia: first identification of a splicing mutation in the fibrinogen gamma chain gene leading to a major gamma chain truncation.
Asselta R; Duga S; Simonic T; Malcovati M; Santagostino E; Giangrande PL; Mannucci PM; Tenchini ML
Blood; 2000 Oct; 96(7):2496-500. PubMed ID: 11001902
[TBL] [Abstract][Full Text] [Related]
14. Missense or splicing mutation? The case of a fibrinogen Bbeta-chain mutation causing severe hypofibrinogenemia.
Asselta R; Duga S; Spena S; Peyvandi F; Castaman G; Malcovati M; Mannucci PM; Tenchini ML
Blood; 2004 Apr; 103(8):3051-4. PubMed ID: 15070683
[TBL] [Abstract][Full Text] [Related]
15. A G-to-A mutation in IVS-3 of the human gamma fibrinogen gene causing afibrinogenemia due to abnormal RNA splicing.
Margaglione M; Santacroce R; Colaizzo D; Seripa D; Vecchione G; Lupone MR; De Lucia D; Fortina P; Grandone E; Perricone C; Di Minno G
Blood; 2000 Oct; 96(7):2501-5. PubMed ID: 11001903
[TBL] [Abstract][Full Text] [Related]
16. Congenital hypofibrinogenemia: characterization of two missense mutations affecting fibrinogen assembly and secretion.
Platè M; Asselta R; Spena S; Spreafico M; Fagoonee S; Peyvandi F; Tenchini ML; Duga S
Blood Cells Mol Dis; 2008; 41(3):292-7. PubMed ID: 18676163
[TBL] [Abstract][Full Text] [Related]
17. Quality control of fibrinogen secretion in the molecular pathogenesis of congenital afibrinogenemia.
Vu D; Di Sanza C; Caille D; de Moerloose P; Scheib H; Meda P; Neerman-Arbez M
Hum Mol Genet; 2005 Nov; 14(21):3271-80. PubMed ID: 16195396
[TBL] [Abstract][Full Text] [Related]
18. Functionally compromised FGG variant (γ320Asp→Glu) expressed at low level in plasma fibrinogen.
Brennan SO; Laurie A
Thromb Res; 2014 Sep; 134(3):744-6. PubMed ID: 25042726
[No Abstract] [Full Text] [Related]
19. Identification and functional characterization of a novel nonsense mutation in FGA accounting for congenital afibrinogenemia in six Egyptian patients.
Abdel Wahab M; de Moerloose P; Fish RJ; Neerman-Arbez M
Blood Coagul Fibrinolysis; 2010 Mar; 21(2):164-7. PubMed ID: 20051841
[TBL] [Abstract][Full Text] [Related]
20. Fibrinogen Nottingham II: a novel Bbeta Arg264gly substitution causing hypofibrinogenaemia.
Hill MB; Brennan SO; Dear A; Strong J; Nejim T; Dolan G
Thromb Haemost; 2006 Sep; 96(3):378-80. PubMed ID: 16953282
[No Abstract] [Full Text] [Related]
[Next] [New Search]
